NCT02383511 - Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG

SMT C1100

Period 1, SMT C1100 1250 mg BID; Period 2, Placebo BID; Period 3, SMT C1100 2500 mg BID

DRUG

SMT C1100

Period 1, SMT C1100 1250 mg BID; Period 2, SMT C1100 2500 mg BID; Period 3, Placebo BID

DRUG

SMT C1100

Period 1, Placebo BID; Period 2, SMT C1100 1250 mg BID; Period 3, SMT C1100 2500 mg BID

Trial Locations (4)

Heart of England NHS Foundation Trust - Heart Lands Hospital, Birmingham

Alder Hey Children's NHS Foundation Trust, Liverpool

Great Ormond Street Hospital for Children NHS Foundation Trust, London

Central Manchester University Hospitals NHS Foundation Trust- Royal Manchester Children's Hospital, Manchester